Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceNIDEK EC-5000 EXCIMER LASER SYSTEM
Generic NameExcimer laser system
ApplicantNIDEK CO., LTD.
34-14 MAEHAMA, HIROISHI-CHO
GAMAGORI, AICHI 443-0-0038
PMA NumberP970053
Supplement NumberS009
Date Received11/23/2005
Decision Date10/11/2006
Product Code LZS 
Docket Number 06M-0460
Notice Date 11/14/2006
Advisory Committee Ophthalmic
Supplement TypePanel Track
Supplement Reason Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL FOR THE NIDEK EC-5000 EXCIMER LASER SYSTEM. THE DEVICE USES A 6.0 MM OPTICAL ZONE AND A 9.0 MM TREATMENT ZONE AND IS INDICATED FOR LASER ASSISTED IN-SITU KERATOMILEUSIS (LASIK): 1) FOR THE REDUCTION OR ELIMINATION OF HYPEROPIA REFRACTIVE ERRORS FROM +0.5 TO +5.0 D OF SPHERE WITH OR WITHOUT ASTIGMATIC REFRACTIVE ERRORS FROM +0.5 TO +2.0 D AT THE SPECTACLE PLANE WITH MANIFEST REFRACTION SPHERICAL EQUIVALENT (MRSE) OF +5.0 D OR LESS; 2) IN PATIENTS 21 YEARS OF AGE OR OLDER; AND 3) IN PATIENTS WITH DOCUMENTED STABILITY OF MANIFEST REFRACTION OVER THE PRIOR YEAR, DEMONSTRATED BY A CHANGE IN MRSE NOT GREATER THAN +/- 0.50 DIOPTER.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
-
-